Spots Global Cancer Trial Database for Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
Official Title: Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
Study ID: NCT04436393
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
Detailed Description: Patients who have been diagnosed with breast cancer and have undergone Guardant360 testing will be approached regarding participation in the study. After being informed about the study and potential risks, all patients providing informed consent and access to their medical records, will provide a list of their health care providers related to their cancer treatment. Data related to their routine clinical care will be abstracted from medical records.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Guardant Health, Redwood City, California, United States
Contact Details
Name: Victoria M Raymond, M.S.
Affiliation: Guardant Health, Inc.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
